Skip to content

Impact of Ventricular Pacing in Unselected ICD/CRT-D Patients

Impact of Ventricular Pacing in Unselected ICD/CRT-D Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01169896
Acronym
FIRST
Enrollment
616
Registered
2010-07-26
Start date
2007-11-30
Completion date
2011-12-31
Last updated
2015-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular Fibrillation, Ventricular Tachycardia

Keywords

Impact of ventricular pacing on the incidence of VT/VF episodes for each models

Brief summary

Observational study is evaluating Ventricular Tachycardia (VT)/Ventricular Fibrillation (VF) thérapies as a function of ventricular pacing

Detailed description

This protocol consists in a non-interventional multi-centre, prospective study. The observational study will also answer the question of the impact of ventricular pacing on the outcome of patients implanted with ICD & CRT-D devices and how the ICD & CRT-D devices are used in clinical practice through two years follow-up.

Interventions

None listed

Sponsors

LivaNova
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Main inclusion Criteria: •Patient implanted (primo implantation or replacement) with an ICD (OVATIO VR 6250, DR 6550, CRT 6750 models, or any similar or higher range device, that includes specific diagnostic and therapeutic functionalities, mandatory to make homogeneous the collection of data) Main

Exclusion criteria

* Presence of a contra-indication to the ICD therapy. * Life expectancy less than 12 months.

Design outcomes

Primary

MeasureTime frameDescription
VT/VF episodes according to ventricular pacing (> and <50%)2 yearsDevice-based data

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026